We are live on
!
Find out more
ORIAW
Orion Biotech Opportunities Corp. Warrant
ORIAW
ORIAW
Delisted
ORIAW was delisted on the 28th of April, 2023.
31 hedge funds and large institutions have $2.18M invested in Orion Biotech Opportunities Corp. Warrant in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
18% more capital invested
Capital invested by funds: $1.85M → $2.18M (+$331K)
7% more funds holding
Funds holding: 29 → 31 (+2)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Holders
31
Holders Change
+2
Holders Change %
+6.9%
% of All Funds
0.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
1
Closed
1
Calls
$549K
Puts
–
Net Calls
+$549K
Net Calls Change
+$5K
Top Buyers
| 1 |
Calamos Advisors
Naperville,
Illinois
|
+$16.2K |
| 2 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$15.1K |
| 3 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$1.99K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$194 |
Top Sellers
| 1 |
KC
Kepos Capital
New York
|
-$4.33K |
| 2 |
CCM
Context Capital Management
Lajolla,
California
|
-$3K |